A Phase 1, Single-arm, Open-label Study to Evaluate the Pharmacokinetics and Safety of Intravenous Difelikefalin in Adult Chinese Subjects on Haemodialysis
Latest Information Update: 16 Feb 2025
At a glance
- Drugs Difelikefalin (Primary)
- Indications Renal failure
- Focus Pharmacokinetics
- Sponsors Vifor Fresenius Medical Care Renal Pharma
- 03 Jun 2024 Status changed from recruiting to completed.
- 05 Jun 2023 New trial record